 |
|
International Normalized Ratio Increase Before Warfarin-Associated Hemorrhage
Brief and Subtle
Nils Kucher, MD;
Shannon Connolly, BA;
Joshua A. Beckman, MD, MS;
Lay Har Cheng, MSPH;
Kanella V. Tsilimingras, RPh;
John Fanikos, RPh, MBA;
Samuel Z. Goldhaber, MD
Arch Intern Med. 2004;164:2176-2179.
Objective To determine the relationship between serial international normalized ratios (INRs) in patients who have been undergoing long-term anticoagulation and the onset of warfarin-associated bleeding complications.
Methods The study cohort consisted of 2391 patients treated in the Anticoagulation Service at Brigham and Women’s Hospital, Boston, Mass, from April 1999 through July 2003. For each patient with a bleeding event, we selected 2 controls who were matched for age, sex, indication for warfarin therapy, and duration of enrollment in our Anticoagulation Service.
Results Warfarin-related hemorrhage occurred in 32 patients (1.3%). The mean ± SD INRs at the time of the bleeding event or matched patient’s event date (5.9 ± 5.9 vs 2.3 ± 0.7; P<.001) and the mean±SD last INRs before the bleeding event or matched patient’s event date (3.0 ± 1.2 vs 2.1 ± 0.8; P<.001) were higher in the patients than in the controls. The last INRs before the bleeding event were obtained an average of 11.6 ± 17.8 (mean ± SD) days before the event in the patients and 18.3 ± 28.0 (mean ± SD) days before the matched date in the controls (P = .22). The mean second-to-last INRs were similar in both groups (2.8 ± 2.1 vs 2.3 ± 0.8; P = .11). When the INRs were plotted in relation to the time before the onset of bleeding, a marked increase in the patients’ INRs was observed shortly before the bleeding began.
Conclusions Serial INRs are poor predictors of hemorrhagic events. There appears to be only a brief warning period during which a slightly elevated INR predicts an imminent bleeding event.
Author Affiliations: Cardiovascular Division (Drs Kucher, Beckman, and Goldhaber and Mss Connolly and Cheng) and Pharmacy Department (Ms Tsilimingras and Mr Fanikos), Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.
RELATED LETTERS
Is Drug Monitoring a Main Cause of Excessive Anticoagulation?
Rachel Howard
Arch Intern Med. 2005;165(3):349.
EXTRACT
| FULL TEXT
A Correct Evaluation of Renal Function Could Decrease Bleeding Risk in Anticoagulated Elderly Patients—Reply
Sophia Koo, Nils Kucher, John Fanikos, and Samuel Z. Goldhaber
Arch Intern Med. 2005;165(3):350.
EXTRACT
| FULL TEXT
Factors Associated With INR Elevation and Bleeding Complications During Warfarin Therapy
Ann K. Wittkowsky
Arch Intern Med. 2005;165(6):703.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Schulman et al.
Chest 2008;133:257S-298S.
ABSTRACT
| FULL TEXT
Falsely Elevated International Normalized Ratio Values in Patients Undergoing Anticoagulation Therapy: A Descriptive Evaluation
Delate et al.
Chest 2007;131:816-822.
ABSTRACT
| FULL TEXT
Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin: Assessment of Incidence, Case-Fatality Rate, Time Course and Sites of Bleeding, and Risk Factors for Bleeding.
Douketis et al.
Arch Intern Med 2006;166:853-859.
ABSTRACT
| FULL TEXT
Factors Associated With INR Elevation and Bleeding Complications During Warfarin Therapy
Wittkowsky
Arch Intern Med 2005;165:703-703.
FULL TEXT
Is Drug Monitoring a Main Cause of Excessive Anticoagulation?
Howard
Arch Intern Med 2005;165:349-349.
FULL TEXT
A Correct Evaluation of Renal Function Could Decrease Bleeding Risk in Anticoagulated Elderly Patients--Reply
Koo et al.
Arch Intern Med 2005;165:350-350.
FULL TEXT
|
